Herpes Vaccine Update: An Interview With Penn's Dr. Harvey Friedman
Many of our readers have asked about the status of Dr. Friedman's trivalent sub-unit herpes vaccine. That's especially so after the failure of Genocea's GEN-003 vaccine candidate. Dr. Friedman, from the University of Pennsylvania, kindly agreed to an interview and his answers should address many of our reader's questions.
